Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
Active, not recruiting · NCT03595592 · Registry updated 2024-03-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer | invasive breast carcinoma | Active, not recruiting | Phase 3 | 2024-03-06 | NCT03595592 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Fondazione Michelangelo | 2 |
| Hoffmann-La Roche | 280 |
65 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.